
NeoGenomics, Inc.
NEO institutional ownership changes in Q2 2026: 92 institutions opened or added positions, 49 trimmed or exited. NEO (NeoGenomics, Inc.) is held by 138 institutional investors as of Q2 2026. Top institutional shareholders: BlackRock, Inc. ($304.5M), First Trust Advisors LP ($147.6M), Vanguard Portfolio Management LLC ($117.6M). Net institutional sentiment: Mixed.
Who's Trading
Latest move
Source dates: Price Nov 5, 2026 · Insiders Oct 5, 2026 · Activists Aug 14, 2026 · Congress Sep 10, 2026
Top Holders
Showing 1-20 of 155
Continue exploring
Other Healthcare stocks held by institutions
Questions investors ask about NEO
Who owns NEO?
138 institutional investors held NEO on June 30, 2026, led by BlackRock, Inc. ($304.5M), First Trust Advisors LP ($147.6M) and Vanguard Portfolio Management LLC ($117.6M).
How many hedge funds hold NEO?
138 institutional investors reported NEO in their 13F filings for the quarter ended June 30, 2026, $1.5B in all. 9 of them are rated Elite.
Are institutions buying or selling NEO?
Buying, on balance. In Q2 2026, 92 institutions opened or added to positions in NEO and 49 institutions trimmed or exited.
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer